SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Non-Tech : Auric Goldfinger's Short List -- Ignore unavailable to you. Want to Upgrade?

To: RockyBalboa who wrote (14888)3/31/2005 10:37:19 AM
From: SEC-ond-chance  Respond to of 19428
 
ABSURD!!! Valuation targets

Based on a standard valuation methodology (see Exhibit A below), we believe the near-term valuation of BIO-heal approaches $660 million, with the prospect of tripling to over $1.5 billion in the coming year.

primepennystock.com



To: RockyBalboa who wrote (14888)3/31/2005 10:41:16 AM
From: SEC-ond-chance  Respond to of 19428
 
Antiviral applications -- the encore

And the biggest market of all, antiviral applications (including AIDS),because BIO-heal has been shown to strengthen the immune system and provide a natural energy boost, which will also lead to athletic supplements, to boost athletic performance and endurance.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News